Elanco Animal Health Inc

ELAN

Latest QuantConomy context for ELAN: asset profile, market coverage, scored signals, and source-linked SEC insider filings when available.

Asset class

stock

Primary venue

NYSE

Recent signals

SEC filings

Asset profile

QuantConomy has a structured record for ELAN. More descriptive asset metadata will appear here when the platform record includes it.

Latest signal rows

Recent signals for ELAN

Scored rows are pulled from the same signal API used by the digests.

Signal	Direction	Score	Observed	Reason
volume major spike	neutral	68	Jul 14, 08:00 PM	ELAN major volume spike: 985% of expected volume for Tuesday 20:00 UTC, price flat 0.31% (strength 68)
volume dry up	neutral	41	Jul 14, 07:03 PM	ELAN volume dry-up: 12% of expected volume for Tuesday 19:00 UTC, price flat 0.04% (strength 41)
volume dry up	neutral	44	Jul 14, 06:19 PM	ELAN volume dry-up: 11% of expected volume for Tuesday 18:00 UTC, price flat 0.02% (strength 44)

EARNINGS signals are experimental: currently limited to neutral pre-earnings calendar awareness (no transcript analysis).

Market	Exchange	Source	Asset record
ELAN	NYSE	fmp	Elanco Animal Health Incorporated
ELAN	NYSE	alphavantage	Elanco Animal Health Inc
ELAN	NYSE	alpaca	Elanco Animal Health Incorporated Common Stock

Buys, last 90d

Sells, last 90d

Rows

Date	Insider	Role	Type	Shares	Price	Value	Filing
Jul 10, 2026	Modi Rajeev A.	SEE REMARKS	grant	60	$24.82	$1,477	4 on EDGAR
Jul 10, 2026	VanHimbergen Robert M	EVP and CFO	grant	8	$24.82	$197	4 on EDGAR
Jul 10, 2026	Simmons Jeffrey N	PRESIDENT, CEO AND DIRECTOR	grant	114	$24.82	$2,827	4 on EDGAR
Jun 30, 2026	Anand Kapila K	Director	grant	584	$24.61	$14,375	4 on EDGAR

Source: SEC filings via QuantConomy. Not investment advice.

Get the data

These rows come from the QuantConomy signal, asset, market, and SEC filings API surfaces, also available to AI agents over MCP.